An intracytoplasmic IL-10 receptor variant permits rapid reduction in STAT3 activation

Genes and Immunity

Volumn 12, Issue 7, 2011, Pages 575-581

  Finsterbusch, M ^a   Khare, V ^a   Campregher, C ^a   Evstatiev, R ^a   Gasche, C ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

inflammation; interleukin 10 receptor 1; single nucleotide polymorphism; STAT

Indexed keywords

GLYCINE; INTERLEUKIN 10 RECEPTOR; JANUS KINASE 1; STAT3 PROTEIN;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVATION; HAPLOTYPE; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WILD TYPE;

CELL CYCLE CHECKPOINTS; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-10 RECEPTOR ALPHA SUBUNIT; JANUS KINASE 1; LIGANDS; PHOSPHORYLATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN BINDING; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 80054874500     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2011.12     Document Type: Article

References (31)

1. Asadullah K, Sterry W, Volk HD. Interleukin-10 therapy- review of a new approach. Pharmacol Rev 2003; 55: 241-269. (Pubitemid 36666048)
2. Glocker EO, Kotlarz D, Boztug K, Gertz EM, Schaffer AA, Noyan F et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med 2009; 361: 2033-2045.
3. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10- deficient mice develop chronic enterocolitis. Cell 1993; 75: 263-274. (Pubitemid 23320290)
4. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989; 170: 2081-2095.
5. Moore KW, de Waal MR, Coffman RL, O?Garra A. Interleukin-and the interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683-765.
6. Wehinger J, Gouilleux F, Groner B, Finke J, Mertelsmann R, Weber-Nordt RM. IL-10 induces DNA binding activity of three STAT proteins (Stat1, Stat3, and Stat5) and their distinct combinatorial assembly in the promoters of selected genes. FEBS Lett 1996; 394: 365-370. (Pubitemid 26341476)
7. Josephson K, Logsdon NJ, Walter MR. Crystal structure of the IL-10/IL-10R1 complex reveals a shared receptor binding site. Immunity 2001; 15: 35-46. (Pubitemid 32728318)
8. Lutfalla G, Gardiner K, Uze G. A new member of the cytokine receptor gene family maps on chromosome 21 at less than kb from IFNAR. Genomics 1993; 16: 366-373.
9. Liu Y, Wei SH, Ho AS, de Waal MR, Moore KW. Expression cloning and characterization of a human IL-10 receptor. J Immunol 1994; 152: 1821-1829.
10. Commins S, Steinke JW, Borish L. The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29. J Allergy Clin Immunol 2008; 121: 1108-1111.
11. Schosser A, Aschauer HN, Wildenauer DB, Schwab SG, Albus M, Maier W et al. Homozygosity of the interleukin-10 receptor G330R allele is associated with schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2007; 144B: 347-350. (Pubitemid 46642026)
12. Hofer H, Neufeld JB, Oesterreicher C, Grundtner P, Wrba F, Gangl A et al. Bi-allelic presence of the interleukin-10 receptor, G330R allele is associated with cirrhosis in chronic HCV-1 infection. Genes Immun 2005; 6: 242-247. (Pubitemid 40645569)
13. Tilg H, van Montfrans C, van den EA, Kaser A, Van Deventer SJ, Schreiber S et al. Treatment of Crohn?s disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gamma. Gut 2002; 50: 191-195. (Pubitemid 34087930)
14. Gasche C, Grundtner P, Zwirn P, Reinisch W, Shaw SH, Zdanov A et al. Novel variants of the IL-10 receptor 1 affect inhibition of monocyte TNF-alpha production. J Immunol 2003; 170: 5578-5582. (Pubitemid 36617847)
15. Grundtner P, Gruber S, Murray SS, Vermeire S, Rutgeerts P, Decker T et al. The IL-10R1 S138G loss-of-function allele and ulcerative colitis. Genes Immun 2009; 10: 84-92.
16. Gruber SG, Gloria LM, Grundtner P, Zdanov A, Gasche C. Differential signaling of cmvIL-10 through common variants of the IL-10 receptor 1. Eur J Immunol 2008; 38: 3365-3375.
17. Wei SH, Ming-Lum A, Liu Y, Wallach D, Ong CJ, Chung SW et al. Proteasome-mediated proteolysis of the interleukin-10 receptor is important for signal downregulation. J Interferon Cytokine Res 2006; 26: 281-290. (Pubitemid 43801011)
18. Usacheva A, Sandoval R, Domanski P, Kotenko SV, Nelms K, Goldsmith MA et al. Contribution of the Box 1 and Box 2 motifs of cytokine receptors to Jak1 association and activation. J Biol Chem 2002; 277: 48220-48226. (Pubitemid 35470773)
19. Usacheva A, Kotenko S,Witte MM, Colamonici OR. Two distinct domains within the N-terminal region of Janus kinase 1 interact with cytokine receptors. J Immunol 2002; 169: 1302-1308. (Pubitemid 34809172)
20. Takane H, Ohdo S, Yamada T, Koyanagi S, Yukawa E, Higuchi S. Relationship between diurnal rhythm of cell cycle and interferon receptor expression in implanted-tumor cells. Life Sci 2001; 68: 1449-1455. (Pubitemid 32168024)
21. Ikegami A, Inoue S, Hosoi T, Kaneki M, Mizuno Y, Akedo Y et al. Cell cycle-dependent expression of estrogen receptor and effect of estrogen on proliferation of synchronized human osteoblast-like osteosarcoma cells. Endocrinology 1994; 135: 782-789. (Pubitemid 24241263)
22. Cassanelli S, Guillaud P, Louis J, Seigneurin D. Image cytometry of progesterone receptor expression during the cell cycle in the MCF-7 cell line. J Histochem Cytochem 1991; 39: 1713-1718.
23. Asadullah K, Eskdale J, Wiese A, Gallagher G, Friedrich M, Sterry W. Interleukin-10 promoter polymorphism in psoriasis. J Invest Dermatol 2001; 116: 975-978. (Pubitemid 32554387)
24. Eskdale J, McNicholl J, Wordsworth P, Jonas B, Huizinga T, Field M et al. Interleukin-10 microsatellite polymorphisms and IL-10 locus alleles in rheumatoid arthritis susceptibility. Lancet 1998; 352: 1282-1283. (Pubitemid 28470346)
25. Hermann J, Gruber S, Neufeld JB, Grundtner P, Graninger M, Graninger WB et al. IL10R1 loss-of-function alleles in rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Rheumatol 2009; 27: 603-608.
26. Crepaldi L, Gasperini S, Lapinet JA, Calzetti F, Pinardi C, Liu Y et al. Up-regulation of IL-10R1 expression is required to render human neutrophils fully responsive to IL-10. J Immunol 2001; 167: 2312-2322. (Pubitemid 32747545)
27. Tamassia N, Calzetti F, Menestrina N, Rossato M, Bazzoni F, Gottin L et al. Circulating neutrophils of septic patients constitutively express IL-10R1 and are promptly responsive to IL-10. Int Immunol 2008; 20: 535-541. (Pubitemid 351426048)
28. Ding Y, Qin L, Zamarin D, Kotenko SV, Pestka S, Moore KW et al. Differential IL-10R1 expression plays a critical role in IL-10-mediated immune regulation. J Immunol 2001; 167: 6884-6892. (Pubitemid 33144181)
29. Williams L, Bradley L, Smith A, Foxwell B. Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages. J Immunol 2004; 172: 567-576. (Pubitemid 38020514)
30. Gruber SG, Gloria LM, Grundtner P, Zdanov A, Gasche C. Differential signaling of cmvIL-10 through common variants of the IL-10 receptor 1. Eur J Immunol 2008; 38: 3365-3375.
31. Matsuzawa A, Tseng PH, Vallabhapurapu S, Luo JL, Zhang W, Wang H et al. Essential cytoplasmic translocation of a cytokine receptor-assembled signaling complex. Science 2008; 321: 663-668.